0001104659-21-067516.txt : 20210517
0001104659-21-067516.hdr.sgml : 20210517
20210517092211
ACCESSION NUMBER: 0001104659-21-067516
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210513
FILED AS OF DATE: 20210517
DATE AS OF CHANGE: 20210517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAREKH RAJESH B
CENTRAL INDEX KEY: 0001429930
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31326
FILM NUMBER: 21928008
MAIL ADDRESS:
STREET 1: ALCHESTER HOUSE, LANGFORD LANE
STREET 2: NORTH WENDLEBURY
CITY: BICHESTER
STATE: X0
ZIP: OX6 ONS
FORMER NAME:
FORMER CONFORMED NAME: PAREKH RAJESH R
DATE OF NAME CHANGE: 20080317
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eloxx Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001035354
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 841368850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (858) 909-0749
MAIL ADDRESS:
STREET 1: 950 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Sevion Therapeutics, Inc.
DATE OF NAME CHANGE: 20140930
FORMER COMPANY:
FORMER CONFORMED NAME: SENESCO TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991006
FORMER COMPANY:
FORMER CONFORMED NAME: NAVA LEISURE USA INC
DATE OF NAME CHANGE: 19970310
4
1
tm2116620d4_4.xml
FORM 4
X0306
4
2021-05-13
0
0001035354
Eloxx Pharmaceuticals, Inc.
ELOX
0001429930
PAREKH RAJESH B
C/O ELOXX PHARMACEUTICALS, INC.
950 WINTER STREET
WALTHAM
MA
02451
1
0
0
0
Common Stock
2021-05-13
4
P
0
84776
1.35
A
171807
I
See footnote
Common Stock
2021-05-13
4
P
0
2381890
1.35
A
4827129
I
See footnote
Reflects the purchase of shares in the offering of Common Stock of Eloxx Pharmaceuticals, Inc. that is expected to close on May 18, 2021.
Held directly by Advent Life Sciences LLP. The Reporting Person is a general partner of Advent Life Sciences LLP. The Reporting Person disclaims beneficial ownership of the reported shares, except to the extent of any pecuniary interest therein.
Held directly by Advent Life Sciences Fund II LP. Advent Life Sciences LLP is the manager of Advent Life Sciences Fund II LP and the Reporting Person is a general partner of Advent Life Sciences LLP. The Reporting Person disclaims beneficial ownership of the reported shares, except to the extent of any pecuniary interest therein.
/s/ Neil S. Belloff, Attorney-in-Fact
2021-05-17